Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Cillis

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Pharmaceuticals (Basel, Switzerland)|May 4, 2026
Current Status of Drug Treatment of Cholangiocarcinoma-Updated Progress and Critical LimitationsJennifer Cillis, Courtney Chen, Supriya Deshpande, et al.
Journal of the American College of Surgeons|October 17, 2025
Oncolytic Properties of the Chimeric Poxvirus HOV-2 in Cholangiocarcinoma ModelsCourtney Chen, Jennifer Cillis, Sang-In Kim, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 24, 2025
Oncolytic Virotherapy in Solid Tumors: A Current ReviewCourtney Chen, Jennifer Cillis, Supriya Deshpande, et al.
Journal for Immunotherapy of Cancer|April 1, 2026
Intraperitoneal CF33-hNIS combined with PD-L1 blockade eradicates gastric cancer peritoneal metastases and prevents recurrence via durable T cell memoryAnnie Yang, Zhifang Zhang, Anthony K Park, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Pharmaceuticals (Basel, Switzerland)|May 4, 2026
Current Status of Drug Treatment of Cholangiocarcinoma-Updated Progress and Critical LimitationsJennifer Cillis, Courtney Chen, Supriya Deshpande, et al.
Journal of the American College of Surgeons|October 17, 2025
Oncolytic Properties of the Chimeric Poxvirus HOV-2 in Cholangiocarcinoma ModelsCourtney Chen, Jennifer Cillis, Sang-In Kim, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 24, 2025
Oncolytic Virotherapy in Solid Tumors: A Current ReviewCourtney Chen, Jennifer Cillis, Supriya Deshpande, et al.
Journal for Immunotherapy of Cancer|April 1, 2026
Intraperitoneal CF33-hNIS combined with PD-L1 blockade eradicates gastric cancer peritoneal metastases and prevents recurrence via durable T cell memoryAnnie Yang, Zhifang Zhang, Anthony K Park, et al.
Pageof 1